Community/Retail

The multi-site study of patients aged 65 years or older examined the levels of vitamin D levels in blood serum, and nutrition and its impact on mobility.

As the role of pharmacists grows into a new phase, the role of the pharmacy technician is expanding as well.

The test can be used to identify large numbers of infected patients and asymptomatic carriers, which would help support containment efforts and slow the spread of the coronavirus disease 2019 (COVID-19).

Caplyta is an oral, once daily medicine approved for the treatment of schizophrenia in adults.

Not enough people are taking seriously frequent recommendations to practice social distancing, he said.

Why is your patient using conjugated estrogens vaginal cream for nosebleeds?

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

The COVID-19 High Performance Computing Consortium is a partnership of federal government, tech industry, and academic leaders whose goal is to stop the virus.

A study of the second HIV patient to undergo successful stem cell transplantation from donors with an HIV-resistant gene found that there was no active viral infection in the patient’s blood 30 months after they stopped antiretroviral therapy.

The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.

Pharmacy Moms Group special task force develops guidelines as precautions are implemented amid the COVID-19 pandemic.

A new commentary suggests that public health leaders should guide world leaders through the coronavirus disease 2019 pandemic.

A report published noted that there are subpopulations of pediatric patients with COVID-19 who have an increased risk for more significant illness.

Steven C. Hoffart, PharmD, owner and operator of Magnolia Pharmacy in Magnolia, Texas, said his pharmacy had run out of prepared hand sanitizer when he saw a need for many people in his area.

The 12 groups represent practice settings of nearly all pharmacists in the United States.

“We’re pretty devastated,” said Jessica Harris, a friend of Rutter, in an interview with WFSB. “She beat cancer and lost the battle to coronavirus—it’s just crazy.”

More than 90% of physicians, nurses, and pharmacists are concerned about COVID-19 affecting their patients, whereas 68% of doctors and 67% of nurses feel they are reasonably prepared for a COVID-19 outbreak in their area.

Four out of 8 manufacturers of hydroxychloroquine, an anti-malarial drug that had shown some success treating the symptoms of the novel coronavirus (COVID-19), are already experiencing shortages.

A new report from the CDC has found that a significant portion of hospitalizations in the United States have come from younger adults.

The study focused on whether moderate alcohol intake is related to reductions in amyloid-beta deposition or is protective via amyloid-independent mechanisms in the living human brain since little information was available.

The FDA has released a statement addressing the issue, stating that the organization is “not aware of scientific evidence connecting the use of NSAIDs, like ibuprofen, with worsening COVID-19 symptoms.”

CVS mistakenly sent unproven information to employees surrounding drinking warm water to combat the novel coronavirus.

All 3 trials reached their primary endpoints, specifically percentage change in low-density lipoprotein cholesterol (LDL-C) from baseline to 17 months and time-adjusted percentage change in LDL-C from baseline from 3 to 18 months.

The findings highlight the critical role played by excess visceral adiposity in the progression of fibrosis among HIV-infected patients with nonalcoholic fatty liver disease, according to the study authors.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

The General Pharmaceutical Council has made plans to temporarily re-register pharmacists and pharmacy technicians should the government launch a state of emergency due to the novel coronavirus.

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

This will be the first global study of tocilizumab in this setting and is expected to begin enrolling in early April, with a target of approximately 330 patients globally.